Pregled bibliografske jedinice broj: 245975
Comparison of protein glycation inhibitory and toxic effects of acetylsalicylic acid in experimental diabetes
Comparison of protein glycation inhibitory and toxic effects of acetylsalicylic acid in experimental diabetes // Acta Pharmaceutica, 42 (1992), 211-218 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 245975 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparison of protein glycation inhibitory and toxic effects of acetylsalicylic acid in experimental diabetes
Autori
Bingulac-Popović, Jasna ; Juretić, Dubravka ; Hadžija, Mirko ; Čepelak, Ivana ; Papić-Futač, Dalja, Slijepčević, Milivoj ; Lipovac, Krešo
Izvornik
Acta Pharmaceutica (1330-0075) 42
(1992);
211-218
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
acetylsalicylic acid; glycation of serum proteins; alanine aminotransferase; N-acetyl-beta-D-glucosaminidase; alanine aminopeptidase
Sažetak
The main objective of the present investigation is to compare the effect of acetylsalicylic acid on glycation of serum proteins in diabetic rats and toxic effect of the applied drug on liver and kidney in non-diabetic rats. Fructosamine test was used for the evaluation of the inhibitory effect of acetylsalicylic acid on an enhanced glycosylation of serum proteins in diabetic rats. Toxic effects on kidney and liver were studied by measuring activities of alanine aminotransferase in serum, N-acetyl-beta-D-glucosaminidase in serum and urine as well as alanine aminopeptidase in urine. This scheme was applied because increased activities of enzymes were present in a poorly controlled diabetes. Inhibitory effect of acetylsalicylic acid on an enhanced protein glycation in diabetic rats was achieved after application of 400 mg kg-1 body mass per day. After 12 days of continuous treatment, only activities of N-acetyl-beta-D-glucosaminidase in urine of seven non-diabetic rats were increased indicating this enzyme to be a sensitive and predictive indicator of drug nephrotoxicity after a short period of treatment. No changes in alanine aminotransferase activities were detected, probably because hepatotoxic reactions can be produced as a cumulative phenomenon requiring more time to develop. Taking into account the observed drug induced damage on the gastric mucosa already after 12 days of treatment it is appropriate to assess the usage of microencapsulated drug in vivo.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Jasna Bingulac-Popović
(autor)
Ivana Čepelak
(autor)
Dubravka Juretić
(autor)
Krešo Lipovac
(autor)
Mirko Hadžija
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus